Cargando…
Is SARS-CoV-2 an oncogenic virus?
Autores principales: | Gómez-Carballa, Alberto, Martinón-Torres, Federico, Salas, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361571/ https://www.ncbi.nlm.nih.gov/pubmed/35961462 http://dx.doi.org/10.1016/j.jinf.2022.08.005 |
Ejemplares similares
-
Pitfalls of barcodes in the study of worldwide SARS-CoV-2 variation and phylodynamics
por: Pardo-Seco, Jacobo, et al.
Publicado: (2021) -
CovidPhy: A tool for phylogeographic analysis of SARS-CoV-2 variation
por: Bello, Xabier, et al.
Publicado: (2022) -
Mapping genome variation of SARS-CoV-2 worldwide highlights the impact of COVID-19 super-spreaders
por: Gómez-Carballa, Alberto, et al.
Publicado: (2020) -
A Timeframe for SARS-CoV-2 Genomes: A Proof of Concept for Postmortem Interval Estimations
por: Pardo-Seco, Jacobo, et al.
Publicado: (2022) -
Phylogeography of SARS-CoV-2 pandemic in Spain: a story of multiple introductions, micro-geographic stratification, founder effects, and super-spreaders
por: Gómez-Carballa, Alberto, et al.
Publicado: (2020)